Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension
To identify predictors of portal hypertension, liver transplantation, and death in North American youth with alpha-1-antitrypsin (AAT) deficiency, and compare with AAT deficiency patients elsewhere.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Jeffrey Teckman, Philip Rosenthal, Kieran Hawthorne, Cathie Spino, Lee M. Bass, Karen F. Murray, Nanda Kerkar, John C. Magee, Saul Karpen, James E. Heubi, Jean P. Molleston, Robert H. Squires, Binita M. Kamath, Stephen L. Guthery, Kathleen M. Loomes, Aver Tags: Original Articles Source Type: research
More News: Alpha-1 Antitrypsin Deficiency | Cholestasis | Hawthorn | Hypertension | Liver | Liver Transplant | Pediatrics | Perinatology & Neonatology | Transplants | Urology & Nephrology | USA Health